Descripción general del mercado mundial de tratamiento de queloides y pronóstico hasta 2031: análisis de mercado y participación de mercado

Mercado mundial de tratamiento de queloides: descripción general de la industria

Las cicatrices queloides son áreas elevadas y engrosadas de tejido cicatricial que se forman en el lugar de una lesión o incisión y se extienden más allá de la herida original. Se producen debido a una sobreproducción de colágeno durante el proceso de curación, lo que hace que el tejido cicatricial crezca excesivamente. Los factores que contribuyen a la formación de queloides incluyen la predisposición genética, la inflamación excesiva y ciertos tipos de piel. El mercado mundial de tratamiento de queloides está experimentando un rápido crecimiento debido a los avances en las tecnologías de tratamiento y un mayor énfasis en el cuidado cosmético y dermatológico. La industria ofrece una amplia gama de terapias, incluidas las inyecciones de corticosteroides, la crioterapia y las técnicas farmacéuticas innovadoras. La biotecnología y los medicamentos personalizados están ganando terreno, lo que brinda nuevas esperanzas para una terapia más efectiva. Las crecientes tasas de incidencia de queloides, junto con un número cada vez mayor de operaciones cosméticas y un mayor deseo de los consumidores por tratamientos estéticos, están impulsando el crecimiento del mercado.

El informe de mercado de Data Bridge Market Research proporciona detalles de los nuevos desarrollos recientes, la participación de mercado, las tendencias del mercado sobre la base de sus segmentaciones y análisis regionales, el impacto de los actores del mercado, análisis de oportunidades en términos de bolsillos de ingresos emergentes, cambios en las regulaciones del mercado, análisis estratégico del crecimiento del mercado, tamaño del mercado, crecimientos del mercado de categorías, nichos de aplicación y dominio, aprobaciones de productos, lanzamientos de productos, expansiones geográficas, innovaciones tecnológicas en el mercado. Para obtener más información sobre el mercado, comuníquese con el equipo de analistas expertos de Data Bridge Market Research. Nuestro equipo lo ayudará a tomar decisiones de mercado informadas para lograr el crecimiento empresarial.

Tamaño del mercado mundial de tratamiento de queloides y análisis del mercado

Continuous innovation is considerably increasing therapeutic efficacy, with an emphasis on reducing side effects and improving patient outcomes. Advances in technology, especially more precise laser systems and specific biologic medicines, are helping to improve the management of keloid scars. The increased emphasis on cosmetic and dermatological treatment drives Global Keloid Treatment Market growth, as patients seek answers to keloids' functional and aesthetic difficulties. As a result Databridge Market Research dived into comprehensively analyzing the market and unveiled that the Global Keloid Treatment Market is increasing at a CAGR of 3.50%. Our detailed analysis forecasts that the market is valued at USD 3.74 billion in 2023 and is expected to grow upto USD 4.93 billion by 2031. Our meticulously created report, developed through comprehensive research and analytics, is a distinguished paper that unveils eye-opening data about the market.

Global Keloid Treatment Market Dynamics

Global Keloid Treatment Market Growth Drivers

Rise in Burn Accidents

According to the World Health Organization, burns cause around 180,000 deaths each year, with the majority of cases occurring in low- and middle-income nations. For instance, the National Health Portal of India reports that approximately 6-7 million people suffer from burn injuries each year. Many individuals who experience severe burns develop keloid scars due to the overproduction of collagen during the healing process. The risk of keloid formation is particularly high in burn victims, as the extensive skin damage and subsequent healing response often lead to excessive scar tissue development. As a result, the global keloid treatment market is expected to grow in response to an increase in burn cases over the forecast period.

Growing Cosmetic and Dermatological Care

The growing focus on cosmetic procedures and dermatological care is significantly driving the demand for keloid treatments. For instance, American Society for Dermatologic Surgery (ASDS) member dermatologists performed nearly 14 million medically necessary and cosmetic procedures in 2019 – 11% more than in 2018 and a 78% increase since 2012. As more individuals seek solutions for both functional and aesthetic skin issues that lead formation of keloid scars, the demand for effective keloid treatments is increasing, highlighting the Global Keloid Treatment Market Growth potential driven by advancements in cosmetic and dermatological care.

Global Keloid Treatment Market Growth Opportunities

Emerging treatment innovations

Emerging treatment innovations for keloids present significant growth opportunities in the global market. Advances in biologic agents and gene-based therapies are leading the way, with JAK inhibitors such as ruxolitinib being investigated for their potential to reduce scar tissue formation by modulating immune responses. Concurrently, gene-editing technologies like CRISPR/Cas9 aim to target and modify genes involved in keloid development, offering new avenues for more effective management.

Advanced surgical procedure

Advanced surgical procedure such as Radiation treatment involves targeted radiation therapy to inhibit the excessive collagen production that characterizes keloid scars, effectively reducing their size and appearance. With increasing adoption and advancements in radiation technology, this method is gaining recognition for its efficacy in preventing keloid recurrence and improving patient outcomes. As awareness and utilization of radiation treatment expand for its effectiveness, it is expected to drive Global Keloid Treatment Market growth.

Global Keloid Treatment Market growth Challenges

Limited Access to Advanced Therapies

Limited access to advanced keloid treatment options, such as novel biologics and state-of-the-art laser therapies, poses a significant challenge to global market growth.  In particular, low-resource settings frequently face barriers to accessing advanced therapies due to high costs, lack of infrastructure, and limited healthcare budgets. Such disparity creates a significant gap in treatment options available to patients in underserved areas, restricting their ability to benefit from the latest advancements in keloid care.

Lack of technical skills.

The exorbitant expense of advanced keloid treatments, such as sophisticated laser therapy and newer biologic medications, is a major impediment to Global Keloid Treatment Market growth. Laser therapies, such as fractional laser resurfacing, can cost thousands of dollars each session, nonetheless biologic medications, aimed at specific pathways implicated in keloid formation, are typically exorbitantly priced due to their complex development and manufacturing processes.

Global Keloid Treatment Market Restraints

Increased regulations constraining the growth of the global Keloid Treatment market

Regulatory hurdles can significantly impact the global keloid treatment market growth, with approval processes varying greatly across different regions. For instance, in countries like India and Brazil, obtaining regulatory approval for new keloid treatments is challenging. In India, the CDSCO requires extensive data and local trials, while Brazil’s ANVISA has a rigorous approval process. These regulatory differences can delay and increase costs for new keloid treatments.

Variability in Treatment Efficacy

Keloid treatment efficacy varies due to individual factors like genetics and keloid location. For instance, corticosteroid injections may be effective for some but less so for others with severe keloids. Similarly, laser therapy might work differently depending on the keloid’s location, complicating the creation of universal treatment protocols and leading to inconsistent patient outcomes. Consequently restraining the Global Keloid Treatment Market growth.

Global Keloid Treatment Market Scope and Trends

• Silicone-based creams have become popular due to their ability to hydrate and create a protective barrier that helps in softening and flattening keloids. Corticosteroid creams, on the other hand, reduce inflammation and collagen production, which can help diminish the size of keloids.
• Intensity-Modulated Radiation Therapy (IMRT) and stereotactic radiosurgery are newer techniques being explored to deliver precise radiation doses to keloid lesions while sparing surrounding healthy tissue.
• Combined surgery and radiation therapy is being explored to reduce keloid recurrence rates. Post-surgical radiation helps to prevent the keloid from reforming by targeting residual fibroblasts and minimizing collagen production.
• Advanced dressings and silicone gel sheeting are used post-operatively to reduce tension and support proper healing. Additionally, customized compression garments are recommended to manage pressure on the treated area and prevent keloid reformation.

Global Keloid Treatment Market Regional Analysis – Market Trends

Key Insights

• The North American keloid treatment market is driven by advanced healthcare infrastructure and high adoption of innovative therapies. The U.S. and Canada have robust regulatory frameworks that support the development and availability of cutting-edge treatments such as biologics and laser therapies.
• En la región de Asia y el Pacífico, el mercado de tratamiento de queloides está experimentando un rápido crecimiento debido al aumento del acceso a la atención médica y la creciente concienciación. Países como Japón, China e India están surgiendo como mercados clave, con un énfasis creciente en las opciones de tratamiento tanto tradicionales como avanzadas.
• El mercado de tratamiento de queloides en América Latina se está expandiendo a medida que mejora la infraestructura de atención médica y aumenta el conocimiento sobre tratamientos avanzados. Brasil y México son mercados importantes, aunque los altos costos y la disponibilidad limitada de terapias de vanguardia pueden obstaculizar el crecimiento del mercado.
• Oriente Medio y África enfrentan desafíos importantes en el mercado de tratamiento de queloides debido a los recursos sanitarios limitados y los diferentes niveles de acceso a tratamientos avanzados. Los mercados clave en la región de Oriente Medio y África incluyen Sudáfrica y Arabia Saudita, donde se están realizando esfuerzos para abordar estos desafíos y ampliar la disponibilidad del tratamiento.

Principales actores del mercado mundial de tratamiento de queloides

• Hoffmann-La Roche Ltd. (Suiza)
• Mylan NV (Estados Unidos)
• Pfizer Inc. (Estados Unidos)
• GSK plc (Reino Unido)
• Novartis AG (Suiza)
• AstraZeneca (Reino Unido)
• Industrias farmacéuticas Sun Ltd. (India)
• Merck & Co., Inc. (Estados Unidos)
• Compañía Bristol-Myers Squibb (Estados Unidos)
• Lilly (Estados Unidos)
• Revitol (Estados Unidos)
• Renovo Group plc (Reino Unido)
• AVITA Medical (Estados Unidos)

Evolución reciente del mercado mundial de tratamiento de queloides

• En abril de 2024, AFT Pharmaceuticals firmó un acuerdo de desarrollo con Massey Ventures y el Instituto de Investigación Gillies McIndoe para proporcionar una terapia tópica para las cicatrices hipertróficas y queloides.
• En enero de 2023, Sonoma Pharmaceuticals, Inc. lanzó una línea de productos de dispensación en el consultorio, que incluye Regenacyn® Plus, Reliefacyn® Plus y Rejuvacyn® Plus, diseñados para profesionales del cuidado de la piel. Regenacyn Plus, en particular, ha demostrado en ensayos clínicos su eficacia para reducir la picazón y el dolor asociados con las cicatrices queloides e hipertróficas, y mejorar su apariencia, textura y color.
• En marzo de 2023, Galderma presentó FACE by Galderma™, una innovadora herramienta de visualización estética que utiliza realidad aumentada (RA) para ayudar a los profesionales estéticos y a los pacientes a visualizar los resultados de los tratamientos inyectables durante la planificación.

SKU-54109